SCHEMBL1506635

SCHEMBL1506635

O=C(O)C=CC(O)C(O)CCCCCCCCCCCCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
PTPN1 P18031 2/20 0.36
SLC15A1 P46059 1/20 0.36
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
GPR84 Q9NQS5 1/20 0.34
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21552032 1.00 FPR2 (0.39) FPR2NFKB1NFKB2RELAPTPN1
SCHEMBL27766971 0.92 FFAR1 (0.35) FPR2NFKB1NFKB2RELAPTPN1
SCHEMBL15287222 0.89 SLC15A1 (0.34) FPR2NFKB1NFKB2RELAPTPN1
SCHEMBL2228459 0.88 ACHE (0.46) FPR2NFKB1NFKB2RELAPTPN1
SCHEMBL4566258 0.86 FPR2 (0.48) FPR2NFKB1NFKB2RELAACHE
SCHEMBL28080055 0.86 FPR2 (0.48) FPR2NFKB1NFKB2RELAACHE
SCHEMBL28337081 0.82 FPR2 (0.34) FPR2NFKB1NFKB2RELAPTPN1
SCHEMBL1015737 0.81 FPR2 (0.56) FPR2NFKB1NFKB2RELAACHE
SCHEMBL1015738 0.81 FPR2 (0.56) FPR2NFKB1NFKB2RELAACHE
SCHEMBL15287182 0.81 ACHE (0.49) PTPN1ACHEBACE1GPR84FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130370-A1 PLANT ACTIVATOR IBIDEN CO., LTD. (JP) 2026-05-14 US claimed
WO-2023212353-A1 VIRAL ENTRY INHIBITORS DERIVED FROM BOTANICALS EMORY UNIVERSITY (US) 2023-11-02 WO claimed
WO-2023146984-A1 LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) 2023-08-03 WO claimed
EP-3810778-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF Genomatica, Inc. (US) 2021-04-28 EP claimed
WO-2019217226-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF REG Life Sciences, LLC (US) 2019-11-14 WO claimed
US-20190033313-A1 METHODS AND SYSTEMS FOR DETECTING MELANOMA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2019-01-31 US claimed
US-20180271046-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2018-09-27 US claimed
US-20170295738-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2017-10-19 US claimed
WO-2016196743-A1 METHODS AND SYSTEMS FOR DETECTING MELANOMA THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-12-08 WO claimed
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug RDINNOVATION APS (DK) 2016-01-21 US claimed
EP-2831151-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDInnovation ApS (DK) 2015-02-04 EP claimed
CN-104245800-A Novel benzene polycarboxylic acid compound RD INNOVATION APS 2014-12-24 CN claimed
WO-2013143549-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDINNOVATION APS (DK) 2013-10-03 WO claimed
US-20130129862-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2013-05-23 US claimed
US-20090285932-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2009-11-19 US claimed
US-20260130370-A1 PLANT ACTIVATOR IBIDEN CO., LTD. (JP) 2026-05-14 US disclosed
WO-2025094894-A1 PLANT ACTIVATOR イビデン株式会社 2025-05-08 WO disclosed
US-4950688-A CONTROLLING SKIN BARRIER FUNCTION; HYDROXY FATTY ACID OR ESTER CONOPCO, INC. (US) 1990-08-21 US disclosed
EP-0097059-B1 SKIN TREATMENT COMPOSITIONS UNILEVER N.V. (NL) 1989-10-25 EP disclosed
EP-0097059-A2 Skin treatment compositions UNILEVER N.V. (NL) 1983-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130370-A1 PLANT ACTIVATOR HAO2, EBP, HAO1 FPR2 888/4885NFKB1 1278/4885NFKB2 731/4885
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug PAH, HPD, PLOD2 FPR2 3168/4885NFKB1 625/4885NFKB2 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.